Textiles & Apparels
Building Material & Construction Sector and Metallurgical Industries
Chemicals Industries
Engineering
Food
Furniture & Wood Industries
Jewellery
Agricultural Industries
Leather & Tanning Industries
 

Pharmaceuticals and Cosmetics Industries


Sector Background:

• The Egyptian pharmaceuticals and cosmetics sector is considered the largest in the region with
regards to growth capacity and expansion during the coming five years compared to similar sectors
in neighboring countries
• Growing increasing of expenditure in this sector reached LE 2.4 billion in 2009. This figure is
expected to hit LE 4.24 billion in 2014 with an annual increase rate of 11.4%.
• Fixing the pharmaceuticals pricing policy shall be a great push for growth during the coming five
years. Medicines should be sold at reasonable prices and this in general will make generics the right
choice as an alternative.
•Egyptian Pharmaceutical sector shall benefit from the availability of raw material manufactures
which leads to reducing imports and costs carried by local pharmaceutical manufacturers.
•Governmental support of Direct Foreign Investment shall help in creating a strong pharmaceutical
industry in Egypt.
•Pharmaceutical Sector in Egypt posses many strengths namely: expansion of local manufacturing,
pharmaceutical exports exceeding market expectations, cheap labor, the need for reasonable price
pharmaceuticals leading to local manufacturing of generics.

2010 data (till the end of August 2010)
  • IMC registered companies reached 145 companies hiring a workforce of 36,000 workers.
  • Export values of IMC registered companies reached LE 577 million in 2008 and LE 826 million in
    2009 with 43% increase. Key markets for Egyptian exports are: the Arab region, African countries,
    Asia and East Europe.
  • Investments of registered companies reached LE 13.5 billion by 2009.

 




Sector Projects :

  • Supporting the cosmetics toll manufacturing for export
    purposes

Specialized services to increase efficiency of the sector:

  • Providing technical assistance related to
    bioequivalence studies to help companies register
    medicines locally and for export purposes as well.
  • R&D Programmes
  • ERP programmes for companies
  • Latest international medicine registration system
    (CTD & ECTD )